Anti-FREM2/ FRASRS2 monoclonal antibody

Anti-FREM2/ FRASRS2 antibody for FACS & in-vivo assay

Target products collectionGo to FREM2/FREM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0452-Ab-1/ GM-Tg-hg-MP0452-Ab-2Anti-Human FREM2 monoclonal antibodyHuman
GM-Tg-rg-MP0452-Ab-1/ GM-Tg-rg-MP0452-Ab-2Anti-Rat FREM2 monoclonal antibodyRat
GM-Tg-mg-MP0452-Ab-1/ GM-Tg-mg-MP0452-Ab-2Anti-Mouse FREM2 monoclonal antibodyMouse
GM-Tg-cynog-MP0452-Ab-1/ GM-Tg-cynog-MP0452-Ab-2Anti-Cynomolgus/ Rhesus macaque FREM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0452-Ab-1/ GM-Tg-felg-MP0452-Ab-2Anti-Feline FREM2 monoclonal antibodyFeline
GM-Tg-cang-MP0452-Ab-1/ GM-Tg-cang-MP0452-Ab-2Anti-Canine FREM2 monoclonal antibodyCanine
GM-Tg-bovg-MP0452-Ab-1/ GM-Tg-bovg-MP0452-Ab-2Anti-Bovine FREM2 monoclonal antibodyBovine
GM-Tg-equg-MP0452-Ab-1/ GM-Tg-equg-MP0452-Ab-2Anti-Equine FREM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0452-Ab-1/ GM-Tg-hg-MP0452-Ab-2; GM-Tg-rg-MP0452-Ab-1/ GM-Tg-rg-MP0452-Ab-2;
GM-Tg-mg-MP0452-Ab-1/ GM-Tg-mg-MP0452-Ab-2; GM-Tg-cynog-MP0452-Ab-1/ GM-Tg-cynog-MP0452-Ab-2;
GM-Tg-felg-MP0452-Ab-1/ GM-Tg-felg-MP0452-Ab-2; GM-Tg-cang-MP0452-Ab-1/ GM-Tg-cang-MP0452-Ab-2;
GM-Tg-bovg-MP0452-Ab-1/ GM-Tg-bovg-MP0452-Ab-2; GM-Tg-equg-MP0452-Ab-1/ GM-Tg-equg-MP0452-Ab-2
Products NameAnti-FREM2 monoclonal antibody
Formatmab
Target NameFREM2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FREM2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FREM2/ FRASRS2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0452
    Target NameFREM2
    Gene ID341640,242022,310418,696113,486002,101087292,527601,100062675
    Gene Symbol and Synonyms6030440P17Rik,8430406N05Rik,b2b1562Clo,CRYPTOP,FRASRS2,FREM2,Gm409,my,ne,nv1,RGD1566012
    Uniprot AccessionQ5SZK8
    Uniprot Entry NameFREM2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000150893
    Target ClassificationN/A

    The target: FREM2, gene name: FREM2, also named as FRASRS2. This gene encodes an integral membrane protein containing numerous CSPG (chondroitin sulfate proteoglycan element) repeats and Calx-beta domains. The encoded protein localizes to the basement membrane, forming a ternary complex that plays a role in epidermal-dermal interactions. This protein is important for the integrity of skin and renal epithelia. Mutations in this gene are associated with Fraser syndrome. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.